Ontology highlight
ABSTRACT: Background
Generalized anxiety disorder is associated with hyperactivity in the amygdala-prefrontal networks, and normalization of this aberrant function is thought to be critical for successful treatment. Preclinical evidence implicates cholinergic neurotransmission in the function of these systems and suggests that cholinergic modulation may have anxiolytic effects. However, the effects of cholinergic modulators on the function of anxiety-related networks in humans have not been investigated.Methods
We administered a novel α7 nicotinic acetylcholine receptor-negative allosteric modulator, BNC210, to 24 individuals (3 male subjects) with generalized anxiety disorder and assessed its effects on neural responses to fearful face stimuli.Results
BNC210 reduced amygdala reactivity to fearful faces relative to placebo and similarly to lorazepam and also reduced connectivity between the amygdala and the anterior cingulate cortex, a network involved in regulating anxious responses to aversive stimuli.Conclusions
These results demonstrate for the first time that the function of disorder-relevant neural circuits in generalized anxiety disorder can be beneficially altered through modulation of cholinergic neurotransmission and suggest potential for this system as a novel target for anxiolytic pharmacotherapy.
SUBMITTER: Wise T
PROVIDER: S-EPMC7198974 | biostudies-literature | 2020 May
REPOSITORIES: biostudies-literature
Wise Toby T Patrick Fiona F Meyer Nicholas N Mazibuko Ndaba N Oates Alice E AE van der Bijl Anne H M AHM Danjou Philippe P O'Connor Susan M SM Doolin Elizabeth E Wooldridge Caroline C Rathjen Deborah D Macare Christine C Williams Steven C R SCR Perkins Adam A Young Allan H AH
Biological psychiatry 20200108 10
<h4>Background</h4>Generalized anxiety disorder is associated with hyperactivity in the amygdala-prefrontal networks, and normalization of this aberrant function is thought to be critical for successful treatment. Preclinical evidence implicates cholinergic neurotransmission in the function of these systems and suggests that cholinergic modulation may have anxiolytic effects. However, the effects of cholinergic modulators on the function of anxiety-related networks in humans have not been invest ...[more]